Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)
Conditions
- Pleural Mesothelioma Malignant
Sponsor
Centro di Riferimento Oncologico - Aviano